Post-Traumatic Stress Disorder - 331-201-00071 (Otsuka)

Clinical trial to examine the efficacy and safety of brexpriprazole combined with sertraline as treatment for adults with posttraumatic stress disorder.

Qualified participants include:

• Adults aged 18 to 65 years old
• Have been diagnosed with posttraumatic stress disorder
• Onset of symptoms for a minimum of 6 months prior to screening

Those that qualify will:

• Receive study drug and study-related care with a board-certified psychiatrist and other clinical staff at no cost.
• Receive reimbursement for study participation and costs.

For more information, contact Ania Poltorak at 860-545-7265 or via email ania.poltorak@hhchealth.org